Dr. D Y Patil Dental College and Hospital, Pimpri, Pune
Pune, Maharashtra, 411018, India
NCT Number: NCT06043687
The study will be a single center, longitudinal prospective, triple blind (investigators, patients and statistician), randomized design. After informed consent, a target population of about 75 healthy adult volunteers with periodontitis will be included in the study. Patients will be randomized and categorized into three experimental groups each containing 25 patients. The randomization process will be carried out by use of sequentially numbered opaque sealed envelopes (SNOSE method).The recording of all the soft tissues data plaque index, gingival index, the modified sulcus bleeding index and the periodontal probing depth and clinical attachment level will be carried out at baseline, 4 weeks, 8 weeks, 12 weeks and will be maintained till 24 weeks for efficacy and safety evaluation.
Looking for future studies?
Notify Me30 year–50 year
All sexes
Interventional
Phase 3
Pune, Maharashtra, 411018, India
Patients will be instructed to brush twice daily. Patients will be instructed to apply at least a 1-inch strip of the toothpaste onto a soft toothbrush and to brush thoroughly for 2 minutes and expectorate. All patients will be instructed to use only the assigned products and refrain from other dentifrice or mouth-rinse during the trial but will be allowed to continue their normal oral hygiene practices. Patients will use the assigned product for a period of 24 weeks for assessment of the efficacy and safety in periodontitis patients.
A complete and detail oral examination will then be conducted to evaluate the oral and perioral region, including soft tissues. Patients will return at study location at 4 weeks, 8 weeks, 12 weeks and 24 weeks for the soft-tissue assessment using the plaque index, gingival index, the modified sulcus bleeding index and the periodontal probing depth and clinical attachment level.
The following objectives will be assessed -
Objectives:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Plaque index (Silness & Löe 1964)>2 Gingival Index (Löe and Silness 1963) >1.5 Modified Sulcus Bleeding Index (Mombelli et al 1987) >1 PPD > 4mm
Exclusion criteria
Scaling and Root planing followed by dentifrice usage
Time frame: Baseline to 24 weeks
Change in Clinical attachment level in chronic periodontitis patients following scaling and root planing & dentifrice usage
Time frame: Baseline to 24 weeks
Change in Probing pocket depth in chronic periodontitis patients following scaling and root planing & dentifrice usage
Time frame: Baseline to 24 weeks
Change in Plaque index levels in chronic periodontitis patients following scaling and root planing & dentifrice usage
Time frame: Baseline to 24 weeks
Change in Gingival index levels in chronic periodontitis patients following scaling and root planing & dentifrice usage
Time frame: Baseline to 24 weeks
Change in mean sulcus bleeding index levels in chronic periodontitis patients following scaling and root planing & dentifrice usage
Dr. D. Y. Patil Dental College & Hospital
Other
Clinical Efficacy of Two Different Dentifrice Formulations in Treatment of Chronic Periodontitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06893107
Chronic Disease, Chronic Periodontitis
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial DetailsNCT04274244
Alveolar Bone Loss, Bone Diseases
Valencia, Spain
View Trial DetailsNCT07671456
Aggressive Periodontitis, Chronic Disease
View Trial DetailsNCT03863249
Alveolar Bone Loss, Bone Diseases
Valencia, Spain
View Trial Details